Filing Details
- Accession Number:
- 0001209191-22-046214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-17 16:03:13
- Reporting Period:
- 2022-08-15
- Accepted Time:
- 2022-08-17 16:03:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326628 | Len Blavatnik | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | Yes | No | |
| 1391297 | Access Industries Holdings Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | Yes | No | |
| 1508226 | Access Industries Management, Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | Yes | No | |
| 1942670 | Ai Biotechnology Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-08-15 | 4,800,000 | $1.31 | 55,911,648 | No | 4 | P | Indirect | By AI Biotechnology LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By AI Biotechnology LLC |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight ordinary shares of the Issuer.
- The price reported represents the purchase price of the ADSs divided by eight.
- The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Billionaire Hedge Funds
